Combined CDK4/6 and PI3K alpha Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer
Zhi Ling Teo, Stephanie Versaci, Sathana Dushyanthen, Franco Caramia, Peter Savas, Chris P Mintoff, Magnus Zethoven, Balaji Virassamy, Stephen J Luen, Grant A McArthur, Wayne A Phillips, Phillip K Darcy, Sherene Loi
Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2017
Related Projects (3)
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by NHMRC
This work was supported by a National Health and Medical Research Council (NHMRC) of Australia Project Grant (1123208; S. Loi, P.K. Darcy, W.A. Phillips). Z.L. Teo was supported by a NHMRC Early Career Fellowship (1106967). P.K. Darcy was supported by a NHMRC Senior Research Fellowship (1041828). S. Loi was supported by the Cancer Council Victoria Australia John Colebatch Fellowship as well as the Breast Cancer Research Foundation NY. S. Loi has received funding to her institution from Novartis and Pfizer.